ONCT लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 01:30):
Our systems believe the stock currently is overvalued by -0.04% compare to its pairs and should correct downwards.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs...

Stats
आज की मात्रा	9 718
औसत मात्रा	6 024
बाजार मूल्य	23.26M
EPS	$-2.83 ( Q1 \| 2024-05-09 )
अगली कमाई की तारीख	( $-3.03 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.640 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.38%

ABIO -1.68%

ABOS 1.64%

ABSI 2.72%

ABUS -2.24%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.73%

ACGN 1.29%

ACHL -4.15%

ACHV -1.83%

ACIU -0.50%

ACLX -0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.15%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.88%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.48%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.28%

ALLR -4.09%

ALNA 3.16%

ALNY 1.69%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.45%

ALVR 0.93%

ALXN 0.00%

ALXO -10.43%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.80%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.22%

ANPC -3.15%

APGE -0.99%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.02%

APLT -4.06%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.89%

ARDS -14.23%

ARDX -0.91%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.47%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.12%

ARWR -1.77%

ASLN -3.44%

ASMB -5.19%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.39%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.59%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.40%

BCTX 8.12%

BCTXW -22.14%

BCYC 0.55%

BDRX -5.18%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.47%

BMRN 0.39%

BNOX -2.22%

BNTC -2.11%

BNTX -1.21%

BOLD -7.90%

BOLT -0.18%

BPMC -1.15%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.88%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.35%

CADL -0.98%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA -0.62%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.94%

CCCC -5.42%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.82%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.81%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -3.31%

CGON -0.32%

CGTX -4.55%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 0.68%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.51%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.14%

COYA -1.46%

CPRX -0.86%

CRBP -1.85%

CRBU -4.83%

CRDF -2.21%

CRGX 1.28%

CRIS -0.38%

CRNX -5.84%

CRSP 1.07%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -2.13%

CTXR 1.03%

CUE 3.63%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.84%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 33.93%

DNLI -1.92%

DNTH -6.35%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX 0.03%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -7.93%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.77%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.48%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.31%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.76%

GHRS -1.94%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.88%

GNPX 0.98%

GNTA 3.94%

GOSS -7.82%

GOVX 5.22%

GOVXW -49.04%

GPCR -6.98%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.08%

HALO -0.80%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 1.97%

HSTO 0.00%

HUMA 1.22%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 18.15%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.47%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.73%

INAB 0.59%

INBX 0.00%

INCY -0.87%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.56%

INSM -0.82%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS 0.07%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.27%

JAZZ -0.40%

JNCE 0.00%

JSPR -5.93%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.91%

KDNY 0.22%

KMPH -0.34%

KNSA -2.68%

KNTE -0.38%

KOD -7.09%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 15.92%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.68%

LENZ -4.02%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.66%

LPCN -5.03%

LPTX -1.11%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.83%

LXRX -2.06%

LYEL -35.45%

LYRA 3.02%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.35%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -2.81%

MGTA -7.74%

MGTX -2.70%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.55%

MNKD -0.95%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -4.03%

MREO -4.42%

MRKR 2.68%

MRNA -4.69%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.25%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.40%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.80%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.62%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.86%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.26%

OCS -1.02%

OCUL -1.90%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.12%

OMER -0.90%

OMGA 5.41%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.56%

ORMP 15.13%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.49%

PBYI 1.69%

PCSA 0.00%

PCVX -0.42%

PDSB -0.79%

PEPG 0.48%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.36%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.35%

PTCT -0.27%

PTE -0.82%

PTGX -1.47%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 2.94%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.89%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.26%

RCKT -7.95%

REGN -0.66%

RENB -3.41%

REPL -2.50%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.39%

RLMD 0.33%

RLYB -0.34%

RNA -0.36%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.32%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.15%

RVMDW -30.00%

RVNC 1.92%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.09%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -4.15%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.50%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.23%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -5.00%

SLGL 4.00%

SLN -4.21%

SLNO -2.71%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.77%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.35%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.87%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -2.90%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.08%

TBPH 0.54%

TCBP 2.74%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.14%

TENX -1.27%

TERN -6.62%

TFFP -3.05%

TGTX -2.66%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -5.98%

TNYA -8.76%

TPST 2.93%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.74%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -8.19%

UBX -2.12%

UNCY -3.38%

URGN -1.28%

UTHR -0.25%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.27%

VERA -2.80%

VERU 0.78%

VERV -2.58%

VIGL 5.11%

VINC 1.62%

VIR 0.87%

VIRI -1.61%

VIRX 2.38%

VKTX -1.13%

VLON -13.04%

VNDA -2.36%

VOR -2.41%

VRCA 0.28%

VRDN -4.15%

VRNA -1.08%

VRPX 0.38%

VRTX 0.33%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -0.10%

XCUR 3.58%

XENE -3.11%

XERS 2.38%

XFOR 3.72%

XLO 1.58%

XLRN 0.00%

XNCR 0.21%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Kisner Daniel L	Buy	2 200	Stock Options
2024-06-20	Carter Michael G	Buy	2 200	Stock Options
2024-06-20	Wills Robert James	Buy	2 200	Stock Options
2024-06-20	Larue William R	Buy	2 200	Stock Options
2024-06-20	Hale David F	Buy	3 300	Stock Options

INSIDER POWER
18.28
Last 100 transactions
Buy: 5 653 801 \| Sell: 3 918 128

सहसंबंध (AI algo v.1.1b): Overvalued: -0.04% $7.86 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Oncternal Therapeutics सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Oncternal Therapeutics वित्तीय

Annual	2023
राजस्व:	$785 000
सकल लाभ:	$-28.97M (-3 690.19 %)
EPS:	$-13.43

FY	2023
राजस्व:	$785 000
सकल लाभ:	$-28.97M (-3 690.19 %)
EPS:	$-13.43

FY	2022
राजस्व:	$1.49M
सकल लाभ:	$1.31M (87.99 %)
EPS:	$-16.50

FY	2021
राजस्व:	$4.32M
सकल लाभ:	$4.32M (100.00 %)
EPS:	$-0.640

Financial Reports:

No articles found.

Oncternal Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Oncternal Therapeutics

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.